SWA
NVS icon

Strategic Wealth Advisors’s Novartis NVS Stock Holding History

Strategic Wealth Advisors’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52K Hold
382
– – 0.04% 100
2026
Q1 		$58K Hold
382
– – 0.05% 93
2025
Q4 		$52K Buy
+382
New +$50K 0.04% 100

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Strategic Wealth Advisors's NVS Position: Q2 2026 in Review

Strategic Wealth Advisors held its Novartis (NVS) position steady in Q2 2026 at 382 shares worth $52K. The position accounts for 0.04% of the portfolio, ranked #100.

Strategic Wealth Advisors first reported a position in NVS in Q4 2025 and has held it in 3 quarters since. The position peaked at $58K in Q1 2026. 1,615 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Strategic Wealth Advisors held 382 shares of Novartis worth $52K as of Q2 2026.
  • Strategic Wealth Advisors left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.04% of Strategic Wealth Advisors's portfolio in Q2 2026, its #100 holding.
  • Strategic Wealth Advisors first reported a position in Novartis in Q4 2025 and has held it in 3 quarters since.
  • Strategic Wealth Advisors's Novartis position peaked at $58K in Q1 2026.
  • 1,615 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Strategic Wealth Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.